-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Benitec Biopharma, Maintains $32 Price Target

Benzinga·03/09/2026 16:20:51
Listen to the news
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Benitec Biopharma (NASDAQ:BNTC) with a Buy and maintains $32 price target.